• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于术前计算机断层扫描成像预测可切除性胰腺导管腺癌的肿瘤细胞密度

Prediction of Tumor Cellularity in Resectable PDAC from Preoperative Computed Tomography Imaging.

作者信息

Jungmann Friederike, Kaissis Georgios A, Ziegelmayer Sebastian, Harder Felix, Schilling Clara, Yen Hsi-Yu, Steiger Katja, Weichert Wilko, Schirren Rebekka, Demir Ishan Ekin, Friess Helmut, Makowski Markus R, Braren Rickmer F, Lohöfer Fabian K

机构信息

Institute of Diagnostic and Interventional Radiology, School of Medicine, Technical University of Munich, 81675 Munich, Germany.

Department of Computing, Faculty of Engineering, Imperial College of Science, Technology and Medicine, London SW7 2AZ, UK.

出版信息

Cancers (Basel). 2021 Apr 25;13(9):2069. doi: 10.3390/cancers13092069.

DOI:10.3390/cancers13092069
PMID:33922981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8123300/
Abstract

BACKGROUND

PDAC remains a tumor entity with poor prognosis and a 5-year survival rate below 10%. Recent research has revealed invasive biomarkers, such as distinct molecular subtypes, predictive for therapy response and patient survival. Non-invasive prediction of individual patient outcome however remains an unresolved task.

METHODS

Discrete cellularity regions of PDAC resection specimen ( = 43) were analyzed by routine histopathological work up. Regional tumor cellularity and CT-derived Hounsfield Units (HU, = 66) as well as iodine concentrations were regionally matched. One-way ANOVA and pairwise t-tests were performed to assess the relationship between different cellularity level in conventional, virtual monoenergetic 40 keV (monoE 40 keV) and iodine map reconstructions.

RESULTS

A statistically significant negative correlation between regional tumor cellularity in histopathology and CT-derived HU from corresponding image regions was identified. Radiological differentiation was best possible in monoE 40 keV CT images. However, HU values differed significantly in conventional reconstructions as well, indicating the possibility of a broad clinical application of this finding.

CONCLUSION

In this study we establish a novel method for CT-based prediction of tumor cellularity for in-vivo tumor characterization in PDAC patients.

摘要

背景

胰腺导管腺癌(PDAC)仍然是一种预后较差的肿瘤实体,5年生存率低于10%。最近的研究已经揭示了一些侵袭性生物标志物,如不同的分子亚型,可预测治疗反应和患者生存情况。然而,对个体患者预后进行无创预测仍然是一项未解决的任务。

方法

通过常规组织病理学检查分析43例PDAC切除标本的离散细胞区域。将区域肿瘤细胞密度与CT衍生的亨氏单位(HU,n = 66)以及碘浓度进行区域匹配。进行单因素方差分析和两两t检验,以评估常规、虚拟单能40keV(单能E 40keV)和碘图重建中不同细胞密度水平之间的关系。

结果

在组织病理学中区域肿瘤细胞密度与相应图像区域的CT衍生HU之间发现了具有统计学意义的负相关。在单能E 40keV CT图像中,放射学鉴别效果最佳。然而,在常规重建中HU值也存在显著差异,表明这一发现具有广泛临床应用可能性。

结论

在本研究中,我们建立了一种基于CT的预测肿瘤细胞密度的新方法,用于PDAC患者体内肿瘤特征的表征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a537/8123300/6a3e91064939/cancers-13-02069-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a537/8123300/71bd314cc08e/cancers-13-02069-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a537/8123300/91812cfafa45/cancers-13-02069-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a537/8123300/6a3e91064939/cancers-13-02069-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a537/8123300/71bd314cc08e/cancers-13-02069-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a537/8123300/91812cfafa45/cancers-13-02069-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a537/8123300/6a3e91064939/cancers-13-02069-g003.jpg

相似文献

1
Prediction of Tumor Cellularity in Resectable PDAC from Preoperative Computed Tomography Imaging.基于术前计算机断层扫描成像预测可切除性胰腺导管腺癌的肿瘤细胞密度
Cancers (Basel). 2021 Apr 25;13(9):2069. doi: 10.3390/cancers13092069.
2
Monoenergetic reconstructions for imaging of coronary artery stents using spectral detector CT: In-vitro experience and comparison to conventional images.使用光谱探测器CT对冠状动脉支架成像的单能重建:体外实验及与传统图像的比较。
J Cardiovasc Comput Tomogr. 2017 Jan-Feb;11(1):33-39. doi: 10.1016/j.jcct.2016.12.005. Epub 2017 Jan 3.
3
Value of spectral detector computed tomography for assessment of pancreatic lesions.光谱探测器 CT 评估胰腺病变的价值。
Eur J Radiol. 2019 Sep;118:215-222. doi: 10.1016/j.ejrad.2019.07.016. Epub 2019 Jul 16.
4
Reduction of artifacts caused by orthopedic hardware in the spine in spectral detector CT examinations using virtual monoenergetic image reconstructions and metal-artifact-reduction algorithms.在光谱探测器CT检查中,使用虚拟单能图像重建和金属伪影减少算法减少脊柱中骨科植入物引起的伪影。
Skeletal Radiol. 2018 Feb;47(2):195-201. doi: 10.1007/s00256-017-2776-5. Epub 2017 Sep 21.
5
Assessment of 70-keV virtual monoenergetic spectral images in abdominal CT imaging: A comparison study to conventional polychromatic 120-kVp images.评估腹部 CT 成像中的 70keV 虚拟单能量谱图像:与传统的 120kVp 多色图像的对比研究。
Abdom Radiol (NY). 2017 Oct;42(10):2579-2586. doi: 10.1007/s00261-017-1151-2.
6
[Monoenergetic Reconstructions Using Detector-based Spectral CT for Imaging of Small Lesions in the Rabbit VX2 Liver Cancer Models].[基于探测器的光谱CT进行单能重建用于兔VX2肝癌模型中小病灶成像]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2018 Oct 30;40(5):651-655. doi: 10.3881/j.issn.1000-503X.10257.
7
Objective and subjective comparison of virtual monoenergetic vs. polychromatic images in patients with pancreatic ductal adenocarcinoma.胰腺导管腺癌患者虚拟单能量与多光谱图像的客观和主观比较。
Eur Radiol. 2019 Jul;29(7):3617-3625. doi: 10.1007/s00330-019-06116-9. Epub 2019 Mar 19.
8
Image quality evaluation of dual-layer spectral detector CT of the chest and comparison with conventional CT imaging.胸部双层光谱探测器CT的图像质量评估及与传统CT成像的比较
Eur J Radiol. 2017 Aug;93:52-58. doi: 10.1016/j.ejrad.2017.05.016. Epub 2017 May 20.
9
Co-clinical Assessment of Tumor Cellularity in Pancreatic Cancer.胰腺癌肿瘤细胞密度的临床联合评估。
Clin Cancer Res. 2017 Mar 15;23(6):1461-1470. doi: 10.1158/1078-0432.CCR-15-2432. Epub 2016 Sep 23.
10
Phantom Validation of Spectral Detector Computed Tomography-Derived Virtual Monoenergetic, Virtual Noncontrast, and Iodine Quantification Images.光谱探测器计算机断层扫描衍生的虚拟单能、虚拟平扫和碘定量图像的体模验证
J Comput Assist Tomogr. 2018 Nov/Dec;42(6):959-964. doi: 10.1097/RCT.0000000000000763.

引用本文的文献

1
Leveraging Artificial Intelligence and Radiomics for Improved Nasopharyngeal Carcinoma Prognostication.利用人工智能和放射组学改善鼻咽癌预后评估
Cancer Med. 2025 Mar;14(6):e70706. doi: 10.1002/cam4.70706.
2
Performance of different CT enhancement quantification methods as predictors of pancreatic cancer recurrence after upfront surgery.不同 CT 增强量化方法在预测术前手术治疗后胰腺癌复发中的表现。
Sci Rep. 2024 Aug 26;14(1):19783. doi: 10.1038/s41598-024-70441-3.
3
Diagnostic Algorithm for Intracranial Lesions in the Emergency Department: Effectiveness of the Relative Brain Volume and Hounsfield Unit Value Measured by Perfusion Tomography.

本文引用的文献

1
Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?胰腺癌的基质靶向治疗:利弊共存?
Front Oncol. 2020 Oct 15;10:576399. doi: 10.3389/fonc.2020.576399. eCollection 2020.
2
Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix.胰腺导管腺癌的进展受到基质的抑制。
J Clin Invest. 2020 Sep 1;130(9):4704-4709. doi: 10.1172/JCI136760.
3
Multiparametric Modelling of Survival in Pancreatic Ductal Adenocarcinoma Using Clinical, Histomorphological, Genetic and Image-Derived Parameters.
急诊科颅内病变的诊断算法:灌注断层扫描测量的相对脑容量和亨氏单位值的有效性
Cureus. 2024 Jun 3;16(6):e61591. doi: 10.7759/cureus.61591. eCollection 2024 Jun.
4
CT Attenuation of Hepatic Pancreatic Cancer Metastases Correlates with Prognostically Detrimental Metastatic Necrosis.肝胰癌转移灶的CT衰减与预后不良的转移灶坏死相关。
J Clin Med. 2023 Nov 26;12(23):7319. doi: 10.3390/jcm12237319.
5
Pancreatic cancer and fibrosis: Targeting metabolic reprogramming and crosstalk of cancer-associated fibroblasts in the tumor microenvironment.胰腺癌与纤维化:靶向肿瘤微环境中代谢重编程和癌相关成纤维细胞的相互作用。
Front Immunol. 2023 Mar 22;14:1152312. doi: 10.3389/fimmu.2023.1152312. eCollection 2023.
6
Functional biomarkers derived from computed tomography and magnetic resonance imaging differentiate PDAC subgroups and reveal gemcitabine-induced hypo-vascularization.源自计算机断层扫描和磁共振成像的功能生物标志物可区分胰腺癌亚组,并揭示吉西他滨诱导的血管减少。
Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):115-129. doi: 10.1007/s00259-022-05930-6. Epub 2022 Sep 8.
7
Epithelial-to-Mesenchymal Transition in Pancreatic Cancer is associated with Restricted Water Diffusion in Diffusion-Weighted Magnetic Resonance Imaging.胰腺癌中的上皮-间质转化与扩散加权磁共振成像中受限的水扩散相关。
J Cancer. 2021 Nov 4;12(24):7488-7497. doi: 10.7150/jca.63633. eCollection 2021.
8
Correlation of in vivo imaging to morphomolecular pathology in translational research: challenge accepted.转化研究中体内成像与形态分子病理学的相关性:接受挑战。
EJNMMI Res. 2021 Aug 28;11(1):83. doi: 10.1186/s13550-021-00826-2.
9
Targeting Fibrosis: The Bridge That Connects Pancreatitis and Pancreatic Cancer.靶向纤维化:连接胰腺炎和胰腺癌的桥梁。
Int J Mol Sci. 2021 May 7;22(9):4970. doi: 10.3390/ijms22094970.
使用临床、组织形态学、遗传学和图像衍生参数对胰腺导管腺癌生存情况进行多参数建模
J Clin Med. 2020 Apr 25;9(5):1250. doi: 10.3390/jcm9051250.
4
Image-Based Molecular Phenotyping of Pancreatic Ductal Adenocarcinoma.基于图像的胰腺导管腺癌分子表型分析
J Clin Med. 2020 Mar 7;9(3):724. doi: 10.3390/jcm9030724.
5
Higher Tumor Cellularity in Resected Pancreatic Ductal Adenocarcinoma Is a Negative Prognostic Indicator.切除的胰腺导管腺癌中较高的肿瘤细胞密度是一个负面的预后指标。
Gut Liver. 2020 Jul 15;14(4):521-528. doi: 10.5009/gnl19180.
6
An image-based deep learning framework for individualizing radiotherapy dose.基于图像的深度学习个体化放疗剂量框架。
Lancet Digit Health. 2019 Jul;1(3):e136-e147. doi: 10.1016/S2589-7500(19)30058-5. Epub 2019 Jun 27.
7
CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses.肺腺癌的 CT 纹理分析:影像组学特征可否作为 EGFR 突变状态的替代生物标志物。
Cancer Imaging. 2018 Dec 14;18(1):52. doi: 10.1186/s40644-018-0184-2.
8
Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential.胰腺导管腺癌中的促纤维增生反应:对病理功能和治疗潜力的见解
Genes Cancer. 2018 Mar;9(3-4):78-86. doi: 10.18632/genesandcancer.171.
9
Improved detection rates and treatment planning of head and neck cancer using dual-layer spectral CT.使用双层光谱 CT 提高头颈部癌症的检出率和治疗计划。
Eur Radiol. 2018 Dec;28(12):4925-4931. doi: 10.1007/s00330-018-5511-2. Epub 2018 May 28.
10
What can we see with IVIM MRI?我们可以通过 IVIM MRI 看到什么?
Neuroimage. 2019 Feb 15;187:56-67. doi: 10.1016/j.neuroimage.2017.12.062. Epub 2017 Dec 22.